From humanising a brand and generating trust to providing meaningful interactions with private professional communities, live video offers many benefits to pharma companies.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh